About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, February 17th, 2015

The QualityStocks
Daily Stock List

graphic
graphic

Thinspace Technology, Inc. (THNS)

PennyStocks24, SuperStockTips, Stock Preacher, Beacon Equity Research, Penny Stock Craze, Penny Stocks Finder, InvestorSoup, Penny Stock Newsletter, Damn Good Penny Picks, PREPUMP STOCKS, Penny Picks, and MoneyTV reported this month on Thinspace Technology, Inc. (THNS), and we are reporting on the Company also, here at the QualityStocks Daily Newsletter.

Port Orange, Florida-based Thinspace Technology, Inc. is a worldwide provider of reliable, scalable, and affordable application delivery, virtualization, and cloud client technology. It provides this technology to public and private sector companies and organizations of all sizes. The Company’s list of private and public sector customers include NASA, PWC, Deutsche Bank, Toyota, and, NHS, local councils, universities, schools, and housing associations. Thinspace Technology has international offices in the United Kingdom (UK), Canada, and India. The Company lists on the OTCQB.

Thinspace Technology operates in high growth B2B markets of application delivery, virtualization and cloud client technology. The Company has over 5,000 enterprise customers globally. Thinspace offers its Propalms TSE. This is an application delivery solution that permits windows applications and desktops to be managed centrally and delivered to users on demand, and to any device regardless of location.

Propalms TSE enhances Windows® Remote Desktop Services (RDS). It provides an on-demand application delivery platform effectively bridging the gap between native RDS and Citrix.

Thinspace Technology also offers its Pano for VDI. The Pano solution includes everything required to deploy virtual desktops on top of VMware or Microsoft virtualization platforms. In one integrated system, users get a choice of  the Company’s inventive award-winning Pano zero client, the new Pano Virtual Client for repurposed PCs/Laptops, and Pano Remote for secure remote access from anywhere.

In addition, the Company’s products include OneGate. This is an application gateway that provides secure remote access to applications using standards based SSL encryption. Thinspace also offers Universal Client. It provides access to applications or Windows desktops from one’s iPad, iPhone, or Android tablet or Smartphone.

Thinspace Technology announced this past December the release of its new skyGate support for mobile devices. The Company’s skyGate version 4.5 includes exclusive support for smartphones and tablets through providing a mobile friendly portal for users to access the hosted applications and virtual desktops via skyGate.

Today, Thinspace Technology announced that Scarborough Public Library in Trinidad and Tobago selected Thinspace Technology for its desktop virtualization solutions.

Mr. Chris Bautista, Thinspace Technology CEO, said, "Customers will have a better user experience as virtual desktops provide the same familiar experience as with PCs and due to the simplicity and affordability of our desktop virtualization solution, more end point devices will be available throughout the library."

Thinspace Technology, Inc. (THNS), closed Tuesday's trading session at $0.146, up 10.61%, on 1,389,774 volume with 321 trades. The average volume for the last 60 days is 244,915 and the stock's 52-week low/high is $0.05/$0.99.

Baltia Air Lines, Inc. (BLTA)

PennyStocks Forever, PennyStocks24, StockHideout, Stock Roach, PennyStockSpy, 007 Stock Chat, Undiscovered Equities, MicrocapVoice and THEOTCBBLIST reported previously on Baltia Air Lines, Inc. (BLTA), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Baltia Air Lines, Inc. is a U.S. start-up airline. The Company’s service is subject to receipt of government operating authority, and as such, no ticket sales are currently available. Baltia is preparing to operate the only non-stop flights for passengers, cargo, and mail from New York's JFK International Airport to Pulkovo Airport in St. Petersburg, Russia.

Baltia Air Lines is the only Part 121 (heavy jet operator) start-up airline in the U.S. today that has received Government fitness approval. The Company has its headquarters at John F. Kennedy International Airport, Jamaica, New York. It has its office/base of operations at Willow Run Airport in Ypsilanti, Michigan. This location will serve as its operations control center. At the Ypsilanti location, an aircraft maintenance contractor will complete major aircraft maintenance on a contract basis.

The Company’s plan is to provide First, Business, as well as Voyager Class accommodations. Its goal is to provide this high quality three-class passenger service, and reliable cargo and mail transportation. Baltia’s aim is to become the leading U.S. airline in the trans-Atlantic market between the major U.S. cities and capital cities of Eastern Europe. This includes Russia, Latvia, Ukraine, and Belarus.
 
Baltia Air Line’s intention is to commence its foreign scheduled air transportation as the only U.S. airline, connecting directly, to two of the world's most prominent cities - New York, New York and St. Petersburg, Russia.

It has identified numerous market segments in the U.S.-Russia market. These are Business Travelers, General Tourism, Ethnic Travelers, Special Interest Groups, Professional Exchanges, and Government and Diplomatic Travel. The Company has passenger service and ground service arrangements at JFK and at Pulkovo Airport in St. Petersburg.

Baltia Air Lines is now in an advanced stage of the FAA Air Carrier Certification process. It announced in October 2014 that it entered into Phase III of the FAA Air Carrier Certification.  This past December, the Company announced that it engaged 121 Inflight Catering LLC as a catering provider.

Baltia Air Lines announced in 2014 that training of its initial corps of stewards was completed on July 29, 2014. Moreover, it announced that training of its initial corps of pilots/check airmen was completed on July 30, 2014.

This month, Baltia announced that the second group of cockpit crewmembers, having completed ground training, has started simulator training. With this new class that adds to the crewmembers who completed the first class, the Company will more than double its cockpit crews.

Baltia Air Lines, Inc. (BLTA), closed Tuesday's trading session at $0.01645, up 2.49%, on 4,071,602 volume with 69 trades. The average volume for the last 60 days is 4,283,385 and the stock's 52-week low/high is $0.008/$0.041.

Epoxy, Inc. (EPXY)

TopPennyStockMovers reported recently on Epoxy, Inc. (EPXY), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

Las Vegas, Nevada headquartered Epoxy, Inc. is the developer of the Epoxy app, which is an application or "app" for iPhone iOS and Android operating systems. Epoxy is an innovative smart phone application. The design of it is to conveniently connect business owners and consumers to reduce marketing frustrations. The Company previously went by the name Neohydro Technologies Corp. It changed its corporate name to Epoxy, Inc. in August of 2014. Epoxy is a fully integrated mobile application business. The Company’s shares trade on the OTC Markets’ OTCQB.

The commitment of Epoxy designers is to providing a superior and user-friendly product for business owners to reward loyal customers. The Epoxy mobile app gives loyal customers the ease of keeping track of rewards and punch cards all in one place. This is while also giving opportunities to review and share businesses with friends.

Successively, Epoxy provides businesses the ability to reward, share offers, and deliver information pertaining to special events with its customers, and offer card-less gift cards directly through smart phones.

Recently, Epoxy announced that it has successfully expanded to New York, New York with the addition of Empowered Hypnosis Centers. In addition, Epoxy has started beta testing in Europe. It has commenced testing in The UAE (United Arab Emirates) and Germany because of repeated requests and overwhelming interest from the regions. Furthermore, Epoxy has been targeting professional business services, including Optometry, Health and Wellness and Technology firms to add to its developing portfolio of clients.

Mr. David Gasparine, Epoxy Chief Executive Officer, stated, "We are very pleased to have grown our business to New York with the addition of Empowered Hypnosis Centers to the Epoxy family. Epoxy has also been Beta testing overseas, in particular the UAE and Germany. We are working in these areas to test the demographics and look to ensure a transition that goes as smooth as possible. We are excited to test the international space as well and make Epoxy as effective as possible."

Epoxy, Inc. (EPXY), closed Tuesday's trading session at $0.096, up 6.79%, on 881,878 volume with 39 trades. The average volume for the last 60 days is 676,278 and the stock's 52-week low/high is $0.0045/$0.18.

Generex Biotechnology Corp. (GNBT)

OTCPicks, PennyTrader Publisher, and Greenbackers reported on Generex Biotechnology Corp. (GNBT), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Toronto, Ontario-based Generex Biotechnology Corp. engages in the research, development, and commercialization of drug delivery systems and technologies. It has developed a proprietary platform technology for the delivery of drugs into the human body by way of the oral cavity, with no deposit in the lungs. The Company’s proprietary liquid formulations enable drugs normally administered via injection to undergo absorption into the body through the lining of the inner mouth using its proprietary RapidMist™ device. Its buccal insulin spray product is Generex Oral-lyn™.

Antigen Express, Inc. is a wholly-owned subsidiary of Generex Biotechnology. The Antigen Express subsidiary is a platform technology and product-based entity. The core platform technologies of Antigen Express consist of immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express is developing proprietary vaccine formulations for active immunotherapy and disease prevention. 

Generex’s RapidMist™ is an advanced buccal drug delivery technology. It comprises a proprietary formulation and a proprietary device design that can deliver drugs through the buccal mucosa safely. RapidMist™ has been shown to have a rapid onset of action with no lung deposition, precise dosage control, easy use and handling, and improved patient compliance.

The Company’s Generex Oral-lyn™ is an insulin spray for the treatment of Type I and Type II diabetes. Generex Oral-lyn™ is a safe, simple, fast, effective, and pain-free alternative to subcutaneous injections of prandial insulin. It is conveniently delivered to the membranes of the oral cavity through a straightforward asthma-like device with no pulmonary (lung) deposition. 

The Antigen Express subsidiary has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One technology centers on the modification of peptides with Ii-Key to increase potency. A second technology relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for strong stimulation of T-helper cells and prevents the further growth of cancer cells. Antigen Express is developing the AE37 breast cancer vaccine.

Generex Biotechnology announced recently its participation in a MedCannAccess partnership with CannScience Innovations, Inc. MedCannAccess announced in December 2014 that it acquired a major minority equity stake in CannScience, a leading cannabinoid drug development firm. This partnership positions MedCannAccess to be a leader in the development of pharmaceutical cannabinoid products.

Today, Generex Biotechnology announced that results of the last pre-specified analysis of data from a Phase II study of a novel cancer vaccine designed to reduce the risk of relapse in patients who have had breast cancer corroborate qualitatively previous results from the primary analysis conducted in January 2014.

Generex Biotechnology’s plan is to disclose the latest results from the Phase II clinical trial at 2015’s American Society of Clinical Oncology (ASCO) Annual Meeting to take place in Chicago, Illinois from May 29 to June 2, 2015. An abstract regarding the results of the Phase II trial has been submitted to the ASCO Annual Meeting. As per ASCO rules, the contents of those abstracts are embargoed pending the meeting.

Generex Biotechnology Corp. (GNBT), closed Tuesday's trading session at $0.0169, up 27.07%, on 2,601,701 volume with 128 trades. The average volume for the last 60 days is 1,450,792 and the stock's 52-week low/high is $0.0105/$0.05.

Amarantus BioScience Holdings, Inc. (AMBS)

Top Stock Picks, TopStockAnalysts, PricelessPennyStocks, PennyStockRumoors.net, BUYINS.NET, SuperNova Elite, Stock Analyzer, Streetwise Reports, PennyStocks24, Pumps and Dumps, Pennybuster, and SmallCapVoice reported on Amarantus BioScience Holdings, Inc. (AMBS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Amarantus BioScience Holdings, Inc. is a biotechnology company based in San Francisco, California. It focuses on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration, and apoptosis. The Company is developing certain biologics surrounding the intellectual property (IP) and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Alzheimer's disease, Traumatic Brain Injury, and other human diseases. Amarantus has an exclusive global license to the Lymphocyte Proliferation test (LymPro Test®) for Alzheimer's disease.

The OTCQB-listed Company has also licensed Eltoprazine, a phase 2b ready indication for Parkinson's Levodopa induced dyskinesia and Adult ADHD. Additionally, it owns the IP rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF). It is developing MANF-based products as treatments for brain disorders. The Company’s lead therapeutic program MANF is a targeted therapeutic to address the underlying Programmed Cell Death (Apoptosis) associated with a broad variety of devastating human disorders.

Moreover, Amarantus BioScience also owns IP for the diagnosis of Parkinson's disease (NuroPro) and the discovery of neurotrophic factors (PhenoGuard™). Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT). This movement started in association with Brewer Sports International (BSI). It is working to raise awareness of new treatments in development for concussions and nervous-system disorders.

Recently, Amarantus BioScience Holdings announced positive effects of Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF) for the protection from vision loss in an animal model of retinitis pigmentosa (RP). MANF was discovered using the Company’s proprietary PhenoGuard™ Protein Discovery Engine.  Furthermore, the Company recently announced that it acquired DioGenix, Inc. DioGenix will be merged into Amarantus Diagnostics as a foundational asset of an emergent neuro-diagnostic business.

Last week, Amarantus BioSciences announced the publication of the results of a Phase 2a study of eltoprazine in Parkinson's disease levodopa-induced dyskinesias (PD-LID). The paper, entitled "Eltoprazine Counteracts L-DOPA-induced Dyskinesias in Parkinson's Disease: A Dose-Finding Study," has been published in Oxford Journals (Oxford University Press) online. It will appear soon in a future print edition of BRAIN - A Journal of Neurology.

Amarantus BioScience Holdings, Inc. (AMBS), closed Tuesday's trading session at $0.0795, up 2.78%, on 1,623,143 volume with 132 trades. The average volume for the last 60 days is 4,192,147 and the stock's 52-week low/high is $0.0489/$0.196.

Pershing Gold Corp. (PGLC)

Streetwise Reports, Lebed.biz, Wall Street Resources, Vantage Wire, StreetAuthority Daily, RedChip, and The Street reported on Pershing Gold Corp. (PGLC), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Pershing Gold Corp. is a gold and precious metals exploration company based in Lakewood, Colorado. The Company is pursuing exploration and development opportunities principally in the State of Nevada. At present, Pershing Gold is on a fast-track to re-open the Relief Canyon Mine, Pershing County, in northwestern Nevada. The Company’s shares trade on the OTC Markets’ OTCQB.

The Relief Canyon Gold Mine is in a major gold and silver trend. Under-explored areas to the north and south of existing open-pits will be explored by Pershing Gold. The Company’s landholdings consist of more than 25,000 acres. This includes the Relief Canyon Mine asset and lands surrounding the mine in all directions. The Relief Canyon Mine property includes three open-pit mines and a state-of-the-art, fully permitted and constructed heap leach processing facility.

Pershing Gold is drilling at Relief Canyon to confirm, expand, and upgrade the gold resource so it can recommence mining. The Company is making strategic acquisitions of mineral targets near the Relief Canyon Mine that will enable it to control a major portion of the Pershing Gold and Silver Trend.

In early December 2014, Pershing Gold announced that Mine Development Associates (MDA) of Reno, Nevada completed a Technical Report for Pershing Gold's Relief Canyon Mine. The MDA Technical Report discusses in detail the resource estimate, previously announced in March 2014, and based on the results from drilling completed through 2013.

The Company’s intention is to update the resource model in early 2015 to include the 2014 drilling results. Upon the updating of the resource estimate, Pershing Gold plans to complete an independent Preliminary Economic Assessment (PEA) to analyze anticipated production rates, cash costs, all-in-sustaining costs, life-of-mine, and other vital factors.

Pershing Gold has also started a diamond drill program at the Buffalo Mountain Project. This is a newly discovered gold and silver target located approximately two miles north of the Relief Canyon Mine. It is in the process of drilling up to 12 holes at Buffalo Mountain.

Last month, Pershing Gold announced that it acquired from Newmont USA Ltd. (NEM) the exclusive mining and surface use rights to roughly 1,600 acres of new long-term mining leases and 74 unpatented lode mining claims consisting of roughly 1,300 acres. The transaction also includes the acquisition of a new 20-year mining lease from New Nevada Lands, LLC, and New Nevada Resources, LLC.

Moreover, last week, Pershing Gold announced that the core-drilling program at the Relief Canyon Mine continues to discover many high-grade gold intercepts that further define a broad zone of high-grade gold mineralization in the North Target Area.

Pershing Gold Corp. (PGLC), closed Tuesday's trading session at $0.364, down 0.27%, on 978,006 volume with 221 trades. The average volume for the last 60 days is 422,930 and the stock's 52-week low/high is $0.26/$0.43.

Max Sound Corp. (MAXD)

TopPennyStockMovers, BUYINS.NET, Greenbackers, and PennyStocks24 reported on Max Sound Corp. (MAXD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Bulletin Board, Max Sound Corp. sells and licenses products and services founded on its Max Sound technology for sound recording and playback. The Company’s emphasis is on licensing its technology to content creators, manufacturers, and network broadcasters. Max Sound serves motion picture, music recording, video game, broadcasting, and Internet video and audio, and consumer electronics markets. Max Sound’s technologies include MAX-D HD Audio and VSL's Optimized Data Transmission Technology. The Company is based in Santa Monica, California.

The MAX-D HD Audio technology has more than 70 filed patents pending. It now can now be found on Qualcomm’s Snapdragon DSP Processors. Qualcomm produces greater than 750 million chips annually, and represents 8 billion dollars of the global chip market. MAX-D HD remains one-tenth the size of a WAV file. Research & Development (R&D) of the MAX-D HD Audio Technologies continues to be the Company’s principal focus now that it has entered its licensing phase.

Max Sound now has a MAX-D API (Application Programming Interface). It allows the MAX-D HD proprietary algorithm and coding to be inserted into applications. These include streaming services, automotive head units, DSP memory in speakers, developer platforms, as well as web-based applications.

Max Sound markets Max Sound technology. The MAX-D Audio Process makes everything sound better. It can convert any audio file to high-definition (HD) quality without increasing its file size. The technology improves varied kinds of audio, and also compressed audio and video as utilized in mp3 files, iPods, Internet, and satellite/terrestrial broadcasting.

In essence, MAX-D is to Audio what HD is to Video. MAX-D is a proprietary audio process. It restores lost, compressed sound harmonics and brings HD sound to digital media. MAX-D improves the sound a listener hears from any device through restoring the lost, compressed sound in real time. This is without increasing the file size.

The Company’s patent pending technology is hardware/platform agnostic. There is no need for a user to change or add equipment.

Max Sound Corp. (MAXD), closed Tuesday's trading session at $0.0375, down 12.22%, on 1,733,941 volume with 79 trades. The average volume for the last 60 days is 886,753 and the stock's 52-week low/high is $0.04/$0.2845.

graphic

The QualityStocks
Company Corner

graphic
graphic

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $9.00, up 80.00%, on 19,895 volume with 27 trades. The stock’s average daily volume over the past 60 days is 183, and its 52-week low/high is $5.00/$15.00.

VistaGen Therapeutics Inc. announced today that the company has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. National Institute of Mental Health (NIMH), part of the U.S. National Institutes of Health (NIH). Under the CRADA, VistaGen and the NIMH will collaborate on an NIH-sponsored Phase 2 clinical study of AV-101, VistaGen's orally-active NMDA receptor modulator, in subjects with Major Depressive Disorder (MDD). MDD is a widespread and debilitating mental disorder affecting millions worldwide, including nearly 7% of U.S. adults.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.

AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder

Dr. Gerard Sanacora Joins VistaGen's Clinical and Scientific Advisory Board

VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder

Save The World Air, Inc. (ZERO)

The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.45, up 0.22%, on 116,090 volume with 37 trades. The stock’s average daily volume over the past 60 days is 113,170, and its 52-week low/high is $0.3401/$1.10.

Save The World Air, Inc. was announced yesterday by QualityStocks as having a new audio interview with Greggory M. Bigger, Chief Executive Officer and Chairman of Save The World, Inc. d/b/a STWA (the "Company") (OTCQX: ZERO) available. The interview can be heard at http://www.QualityStocks.net/interview-zero.php.

Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.

In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.

The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.

STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.

Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer

Save The World Air, Inc. Company Blog

Save The World Air, Inc. News:

STWA (ZERO) Key Management Featured in Exclusive QualityStocks Interview

STWA (OTCQX: ZERO) Announces Engagement of QualityStocks Investor Relations Services

STWA Appoints Energy Industry Executive Thomas A. Bundros to Board of Directors

eCareer Holdings, Inc. (ECHI)

The QualityStocks Daily Newsletter would like to spotlight eCareer Holdings, Inc. (ECHI). Today, eCareer Holdings, Inc. closed trading at $0.30, even for the day, on 700 volume with 2 trades. The stock’s average daily volume over the past 60 days is 1,088 and its 52-week low/high is $0.30/$4.00.

eCareer Holdings, Inc. announced today that the company has engaged the investor relations services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value. QualityStocks will utilize its vast network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to facilitate enhanced communication between eCareer and its shareholders while raising the Company's visibility in the broader investment community. 

eCareer Holdings, Inc. (ECHI) is an early-stage internet company working to organize the online hiring process by creating content-rich, profession-specific communities. By fully integrating its personalized career centers with matching branded professional and social networks, the company creates a solution for employers and professionals to enjoy the very best user experience.

The company’s development of branded career websites focuses on specialized “Internet Job Verticals,” which allow for some of the most effective job advertising platforms on the market. Through the use of superior technological solutions, eCareer Holdings plans to address the high demand for skilled professionals in a variety of narrow sectors while simultaneously attracting potential clients with strong advertising budgets.

Headquartered in Boca Raton, Florida, eCareer Holdings launched its first site, Openreq™, in January 2013. Using advanced software solutions, the site provides staffing, recruiting and human resource professionals with access to job openings in their desired sector. With a single post to Openreq, companies can reach over 1,300 sites including popular social networking destinations such as Indeed, Glassdoor, Facebook and SimplyHired. The company is also currently developing Cardiologist.com and BioFuel Zone, which are planned for release in the near future.

Led by a team of experienced executives headed by Chief Executive Officer Joseph J. Azzata, eCareer Holdings is persistently working to refine its effective job database solutions. With a range of unique features including industry news, social media groups, webinars, events, training programs and consolidated industry statistics, eCareer Holdings continues to engage in the design and development of revolutionary career websites aimed at recruiters, staffing companies and government agencies. Disclaimer

eCareer Holdings, Inc. Blog

eCareer Holdings, Inc. News:

eCareer Announces Engagement of QualityStocks Investor Relations Services

eCareer Relaunches Openreq With Revolutionary Job Matching Technology

eCareer Holdings, Inc. Awarded by South Florida Business Journal as a "Best Place to Work"

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0058, off by 6.45%, on 9,633,186 volume with 109 trades. The stock’s average daily volume over the past 60 days is 4,147,576, and its 52-week low/high is $0.0008/$0.2998.

One World Holdings, Inc. subsidiary, The One World Doll Project, announced today that it has released an interview with its Founder, Trent T. Daniel, in which he discusses the company's appearance at The 112th North American International Toy Fair this and last week in New York City. While at the Toy Fair the company confirmed that it had meetings with representatives or buyers from major big box retailers including Walmart, Toy R Us and Kroger/Fred Meyer. From these meetings, One World CEO, Corinda Joanne Melton, also confirmed that the company will be securing purchase orders for expanded online and retail locations placements within the next few weeks.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

The One World Doll Project Founder Interviews With CEOLIVE.TV; Updates on Toy Fair 2015

The One World Doll Project Founder Interviews With CEOLIVE.TV; Updates on Amazon.com Deal, 2015 Product Line Expansion and Toy Fair

The One World Doll Project Announces First Order From Amazon.Com

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.006, up 50.00%, on 230,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 68,858, and its 52-week low/high is $0.0016/$0.018.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Falcon Crest Energy (FCEN)

The QualityStocks Daily Newsletter would like to spotlight Falcon Crest Energy (FCEN). Today, Falcon Crest Energy closed trading at $0.0159, up 2.58%, on 100,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 7,313, and its 52-week low/high is $0.0066/$0.095.

Falcon Crest Energy (FCEN) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Falcon Crest Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Falcon Crest Energy has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Falcon Crest Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Falcon Crest Energy Company Blog

Falcon Crest Energy News:

Falcon Crest Energy Acquires Remaining Working Interest in Rocky Ford Field

Falcon Crest Names Michael Cvetanovic to Advisory Council

Falcon Crest Energy Announces Powder River Basin Leasehold Acquisition

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0385, up 0.55%, on 84,000 volume with 18 trades. The stock’s average daily volume over the past 60 days is 106,471, and its 52-week low/high is $0.03/$0.855.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(VSTA)

2.

PennyStocks24
(CSRH)

3.

TopPennyStockMovers
(LEI)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251